Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RECKing MMP function: implications for cancer development.

Jin-Sae Rhee1, Lisa M Coussens

  • 1Medical Scientist Training Program and Cancer Research Institute, University of California, San Francisco, 2340 Sutter St, 94143, USA.

Trends in Cell Biology
|June 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert opinion on burning questions in cancer myeloid cell biology.

Journal for immunotherapy of cancer·2026
Same author

Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies.

Cancer research communications·2026
Same author

Plectin promotes an aggressive phenotype and represses cytotoxic T cell activity in pancreatic cancer.

bioRxiv : the preprint server for biology·2026
Same author

scSurvival: Single-Cell Survival Analysis of Clinical Cancer Cohort Data at Cellular Resolution.

Cancer discovery·2026
Same author

Hallmarks of Cancer: How did it inspire you?

Cell·2026
Same author

Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment.

Immunity·2026

RECK, a novel cell-surface inhibitor, regulates matrix metalloproteinases (MMPs) involved in cancer progression. Loss of RECK impairs tumor development, supporting protease inhibitors as cancer therapeutics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer involves genetic and epigenetic changes in tumor and stromal cells.
  • Matrix metalloproteinases (MMPs) regulate malignant progression.
  • RECK is a newly identified cell-surface inhibitor of MMPs.

Purpose of the Study:

  • To investigate the role of RECK in regulating MMPs.
  • To understand RECK's function in embryogenesis and tumorigenesis.
  • To evaluate protease inhibitors as anticancer therapeutics.

Main Methods:

  • Analysis of RECK's function in cellular signaling.
  • Studying the effects of RECK deficiency in embryonic development.
  • Assessing tumor development in adult models with RECK loss.

Related Experiment Videos

Main Results:

  • RECK regulates MMP-induced pericellular signaling.
  • Homozygous loss of RECK leads to embryonic lethality.
  • RECK deficiency attenuates tumor development in adult organisms.

Conclusions:

  • RECK plays a crucial role in development and tumor suppression.
  • Targeting MMPs via inhibitors like RECK shows therapeutic potential for cancer.